期刊文献+

IL27RA对EBV感染的鼻咽癌细胞TRAF1/2表达的调控及其生物学效应 被引量:2

Regulation on TRAF1/2 Expression and Biological Effect of IL27RA in NPC Cells with EBV
原文传递
导出
摘要 EB病毒(Epstein-Barr virus,EBV)感染是鼻咽癌(Nasopharyngeal carcinoma,NPC)最主要的危险因素,主要通过肿瘤坏死因子受体相关分子-1/2(Tumor necrosis factor receptor-associated factor-1/2,TRAF1/2)发挥促癌作用,为探究白介素27受体亚基α(Interleukin 27 receptorα,IL27RA)表达与NPC细胞EBV感染的关系及其生物学效应,本研究采用肿瘤基因组计划(The Cancer Genome Atlas,TCGA)数据库在NPC组织中筛选EBV感染相关信号分子TRAF1/2的潜在相互作用分子,培养携带EBV的NPC细胞株HK-1和C666-1及未携带EBV的NPC细胞株CNE-1及CNE-2,实时荧光定量PCR技术(RT-qPCR)及蛋白质印迹技术(Western Blot)检测IL27RA mRNA及蛋白表达,慢病毒介导细胞转染技术外源性干扰HK-1和C666-1细胞IL27RA的表达,CCK-8检测细胞增殖能力的变化情况,Transwell实验检测细胞侵袭能力的变化情况。结果显示,NPC组织中存在与TRAF1/2表达均显著正相关的分子IL27RA(相关系数R分别为0.61及0.69,P均小于0.001),同时IL27RA在NPC组织中高表达(P<0.001),HK-1和C666-1中IL27RA mRNA及蛋白的表达水平显著高于CNE-1及CNE-2细胞(P<0.01),干扰HK-1和C666-1细胞IL27RA表达后,TRAF1及TRAF2 mRNA及蛋白表达显著下调(P<0.01),且细胞增殖及转移能力均显著减弱(P<0.01)。本研究提示,干扰IL27RA表达可显著抑制携带EBV的NPC细胞TRAF1/2的表达及细胞增殖转移能力,IL27RA有望成为NPC新的分子靶标或标志物。 Epstein-Barr virus(EBV) infection is the most important risk factor of nasopharyngeal cancer(NPC),and it plays a role in promoting NPC through TNF receptor associated factor-1/2(TRAF1/2). To investigate the relationship between the expression of interleukin 27 receptor α(IL27RA)and EBV infection in NPC cells and biological effect of IL27RA,the Cancer Genome Atlas(TCGA)database was used to screen the potential interaction molecule of TRAF1/2,a signal molecule related to EBV infection. Culture HK-1 and C666-1(NPC cell lines carrying EBV)and CNE-1 and CNE-2(NPC cell lines without EBV). Real-time fluorescent quantitative PCR(RT-qPCR)and Western Blot were used to detect IL27RA mRNA and protein expression. Lenti-transfection technology was used to interfere with the expression of IL27RA in HK-1 and C666-1 cells exogenously. CCK-8 assay was used to detect the change of cell proliferation ability,and Transwell assay was used to detect the change of cell invasion ability. Results showed that IL27RA was positively correlated with the expression of TRAF1 and TRAF2 in NPC(the correlation coefficients R were0.61 and 0.69 respectively,P<0.001),and the expressions of IL27RA in NPC tissues were significantly higher than normal tissues(P<0.001). The mRNA and protein expression of IL27RA in HK-1 and C666-1 was significantly higher than that in CNE-1 and CNE-2(P<0.01). After interfering with the expression of IL27RA in HK-1 and C666-1 cells,the mRNA and protein expression of TRAF1 and TRAF2 were significantly upregulated(P<0.01). The ability of cell proliferation and metastasis were significantly weakened(P<0.01).The present study suggested that interference with IL27RA expression can significantly inhibit the expression of TRAF1/2 and cell proliferation and metastasis ability of NPC cells with EBV. IL27RA is expected to become a new molecular target or marker of NPC.
作者 高艳丽 苏影 GAO Yanli;SU Ying(Laboratory Department of Liao yang Central Hospital,Liao yang 111000,China;Pathology Department of Zhejiang Cancer Hospital,Hangzhou 310022,China)
出处 《病毒学报》 CAS CSCD 北大核心 2020年第2期262-269,共8页 Chinese Journal of Virology
关键词 鼻咽癌(NPC) EB病毒(EBV) 白介素27受体亚基α(IL27RA) 恶性表型 Nasopharyngeal cancer(NPC) Epstein-Barr virus(EBV) Interleukin-27 receptor subunitα(IL27RA) Malignant phenotype
  • 相关文献

参考文献1

二级参考文献30

  • 1Johansson P, Jansson A, Ruetschi U, et al. The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene[J]. J Virol, 2010, 84(6): 2787-2797.
  • 2Tao YG, Tan YN, Liu YP, et al. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner[J]. Cell Signal, 2004, 16(7): 781-790.
  • 3Fang W, Zhang J, Hong S, et al. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy[J]. Oncotarget, 2014, 5(23): 12189-12202.
  • 4Dawson CW, Laverick L, Morris MA, et al. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway[J]. J Virol, 2008, 82(7): 3654-3664.
  • 5Vaysberg M, Lambert SL, Krams SM, et al. Activation of the JAK/STAT pathway in Epstein Barr virus +-associated posttransplant lymphoproliferative disease: role of interferon-gamma[J]. Am J Transplant, 2009, 9(10): 2292-2302.
  • 6Yang CF, Yang GD, Huang TJ, et al. EB-virus latent membrane protein 1 potentiates the sternness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop[J]. Oncogene, 2015, 402: 1-13.
  • 7Yamasaki L. Role of the RB tumor suppressor in cancer[J]. Cancer Treat Res, 2003, 115: 209-239.
  • 8Yang L, Liu L, Xu Z, et al. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma[J]. Oncotarget, 2015, 6(8): 5804-5817.
  • 9Lain N, Sugden B. CD40 and its viral mimic, LMPI: similar means to different ends[J]. Cell Signal, 2003, 15(1): 9-16.
  • 10Yoshimori M, Imadome K, Komatsu H, et al. CD137 expression is induced by Epstein-Barr virus infection through LMP1 in T or NK cells and mediates survival promoting signals[J]. PLoS One, 2014, 9(11): el 12564.

共引文献3

同被引文献22

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部